G
Gabriella d'Ettorre
Researcher at Sapienza University of Rome
Publications - 262
Citations - 5310
Gabriella d'Ettorre is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Viral load & Population. The author has an hindex of 33, co-authored 262 publications receiving 3972 citations. Previous affiliations of Gabriella d'Ettorre include Policlinico Umberto I & Pasteur Institute.
Papers
More filters
Journal ArticleDOI
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review.
Gabriele d'Ettorre,Giancarlo Ceccarelli,Letizia Santinelli,Paolo Vassalini,Giuseppe Pietro Innocenti,Francesco Alessandri,Alexia E. Koukopoulos,Alessandro Russo,Gabriella d'Ettorre,Lorenzo Tarsitani +9 more
TL;DR: In this paper, a review aims to analyze the literature to discover which topics have been focused on and what the latest developments are in managing the occupational risk of post-traumatic stress symptoms (PTSS) in healthcare workers during the current COVID-19 pandemic.
Journal ArticleDOI
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review.
Fabio Infusino,Massimiliano Marazzato,Massimo Mancone,Francesco Fedele,Claudio Maria Mastroianni,Paolo Severino,Giancarlo Ceccarelli,Letizia Santinelli,Elena Cavarretta,Antonino G.M. Marullo,Fabio Miraldi,Roberto Carnevale,Cristina Nocella,Giuseppe Biondi-Zoccai,Cristiano Pagnini,Sonia Schiavon,Francesco Pugliese,Giacomo Frati,Gabriella d'Ettorre +18 more
TL;DR: There are no specific data available, and rigorous clinical trials should be conducted to confirm the putative benefits of diet supplementation, probiotics, and nutraceuticals in the current pandemic, but large scientific evidence supports the benefits that some bacterial and molecular products may exert on the immune response to respiratory viruses.
Journal ArticleDOI
Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19
Gabriella d'Ettorre,Giancarlo Ceccarelli,Massimiliano Marazzato,Giuseppe Campagna,Claudia Pinacchio,Francesco Alessandri,Franco Ruberto,Giacomo Rossi,Luigi Celani,Carolina Scagnolari,Cristina Mastropietro,Vito Trinchieri,Gregorio Egidio Recchia,Vera Mauro,Guido Antonelli,Francesco Pugliese,Claudio Maria Mastroianni +16 more
TL;DR: A specific bacterial formulation showed a significant ameliorating impact on the clinical conditions of patients positive for SARS-CoV-2 infection, stressing the importance of the gut-lung axis in controlling the COVID-19 disease.
Journal ArticleDOI
Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the “Probio-HIV” Clinical Trial
Gabriella d'Ettorre,Giancarlo Ceccarelli,Noemi Giustini,Sara Serafino,Nina Calantone,Gabriella De Girolamo,Luigi Bianchi,Valeria Bellelli,Tommaso Ascoli-Bartoli,Sonia Marcellini,Ombretta Turriziani,Jason M. Brenchley,Vincenzo Vullo +12 more
TL;DR: It is observed that cART does not normalize the levels of immune activation in HIV positive patients anyway inflammation and markers of microbial translocation were significantly reduced with probiotic supplementation.
Journal ArticleDOI
HIV-Associated Immune Activation: From Bench to Bedside
TL;DR: An update on the causes and consequences of the HIV-associated immune activation, and a summary of the immune modulatory approaches that are currently under clinical investigation are provided.